Enanta Pharmaceuticals (ENTA) Revenue: 2012-2025
Historic Revenue for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to $15.1 million.
- Enanta Pharmaceuticals' Revenue rose 3.55% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.3 million, marking a year-over-year decrease of 3.42%. This contributed to the annual value of $65.3 million for FY2025, which is 3.42% down from last year.
- Per Enanta Pharmaceuticals' latest filing, its Revenue stood at $15.1 million for Q3 2025, which was down 17.41% from $18.3 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Revenue registered a high of $27.6 million during Q4 2021, and its lowest value of $14.6 million during Q3 2024.
- Moreover, its 3-year median value for Revenue was $17.8 million (2023), whereas its average is $17.1 million.
- Over the last 5 years, Enanta Pharmaceuticals' Revenue had its largest YoY gain of 15.93% in 2021, and its largest YoY loss of 27.11% in 2021.
- Quarterly analysis of 5 years shows Enanta Pharmaceuticals' Revenue stood at $27.6 million in 2021, then decreased by 14.70% to $23.6 million in 2022, then decreased by 23.67% to $18.0 million in 2023, then decreased by 5.80% to $17.0 million in 2024, then increased by 3.55% to $15.1 million in 2025.
- Its Revenue was $15.1 million in Q3 2025, compared to $18.3 million in Q2 2025 and $14.9 million in Q1 2025.